The Venture Codex

Participated · Series B · May 2022

FINN operates a multi-brand car subscription service that lets customers subscribe to vehicles fully online with insurance, registration, taxes, and servicing bundled into a single monthly fee and flexible cancellation. The platform features more than 25 brands including BMW, Mercedes-Benz, Hyundai, BYD, and MG. FINN has grown rapidly since its 2019 founding in Munich, reaching over 50,000 active subscriptions and annual recurring revenue of more than €300 million. Reported revenue rose from €3.2 million in 2022 to €444 million in 2024, representing a two-year compound annual growth rate of 1,078%. The company employs roughly 484 people as of 2025 and plans to expand its subscription fleet, improve profitability, and continue enhancing its technology. FINN faces competition from players like Sixt+, Onto, and Free2Move and acknowledges macroeconomic sensitivity given subscription pricing versus traditional leasing.

Participated · Series A · Feb 2022

Terray Therapeutics develops small‑molecule therapeutics by combining generative AI, ultra‑high‑throughput experimentation, biology, medicinal chemistry, automation, and nanotechnology. Its integrated AI platform, tNova, and chemistry foundation model COATI power both internal programs and partnered discovery efforts. The company reports it has quantitatively measured more than 5 billion target–ligand interactions in the past three years—roughly 50× the entirety of publicly available chemistry data—and that this dataset is doubling annually. Terray applies these capabilities to an internal pipeline focused on immunological diseases and to multi‑target partnerships with Bristol Myers Squibb and Calico. Proceeds from the Series B will advance internal programs into the clinic and expand the tNova platform and associated AI tools. Since its Series A in 2021, Terray has raised over $200 million in equity financing to date. Terray Therapeutics, led by CEO Jacob Berlin, develops small-molecule therapeutics by integrating generative AI with high-throughput experimentation, biology, medicinal chemistry, automation, and nanotechnology. Its platform combines experimentation and computation to build ligand- and structure-based models aimed at accelerating discovery of challenging therapeutic targets. The company plans to develop comprehensive chemistry foundation models and will leverage NVIDIA DGX Cloud and the NVIDIA BioNeMo cloud service to scale and optimize those models. Terray intends to use its proprietary experimental datasets to train both ligand-based and structure-based generative models to propel its pipeline toward the clinic. Financially, Terray received an investment from NVentures alongside a syndicate of new and existing institutional investors; the amount of the financing was not disclosed. Named individual investors in the syndicate include John Maraganore and Bassil Dahiyat. Terray Therapeutics builds integrated computational and experimental platforms that generate scaled, agnostic chemical data to power computational learning and reveal new molecular interactions. The company combines AI, synthetic chemistry, automation and nanotechnology to propel drug discovery into the information age. Terray is led by CEO Jacob Berlin and is advancing a preclinical pipeline alongside discovery partnerships. The company intends to use the Series A proceeds to advance its preclinical programs and its discovery collaborations. This Series A follows a previously unannounced $20 million seed round co-led by Digitalis Ventures and Two Sigma Ventures. Terray is headquartered in Pasadena, California.

Participated · Series F · Jan 2022

Creditas has built an integrated financial services platform that combines secured lending with complementary insurance and investment products, all delivered through a technology-first, customer-centric approach. The company’s offering now expands into full banking and wealth-management capabilities through its recently completed acquisition of Andbank Brazil, approved by the Brazilian Central Bank. Management views the deal as the consolidation of a complete ecosystem that unites credit, insurance and investments under one roof. Creditas continues to strengthen its leadership bench, hiring former BBVA executive Ricardo Forcano as Chief Technology & Operations Officer to oversee Technology, Operations and People. The initial close of its Series G financing pegs the firm’s valuation at USD 3.3 billion, underscoring investor confidence in its growth trajectory. VEF, an early backer, converted its outstanding convertible loans into equity in this round at a lower valuation, yet still recorded a positive uplift in its reported NAV. No revenue or user figures were disclosed in the article, but the company is characterised as one of Latin America’s foremost fintechs.